Neuroendocrine tumors (NETs) form from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, phechromocytomas and Merkel cell cancers.
Neuroendocrine tumors are often small and can be malignant (cancerous) or benign (non-cancerous).
Patients with NETs are treated at Penn by a multidisciplinary team of cancer specialists who see more patients with gastrointestinal (GI) cancers in one year than many doctors see in their careers.
In addition, the Neuroendocrine Tumor Center at Penn offers patients:
- A tumor board: A treatment planning approach in which the NET team reviews and discusses the medical condition and treatment options of a patient.
- Nurse navigators: Specialty nurses available to guide patients through the appointment and treatment process.
- A single point of contact.
Who Should Attend the NET Conference?
The Focus On Neuroendocrine Tumors conference is for people who are newly diagnosed, currently in treatment or long-term survivor of:Gastrointestinal Tract NETs including:
- Pancreatic NETs (hereditary or sporadic)
- Zollinger-Ellison syndrome (gastrinomas)
- Insulinomas
- Alimentary tract NETs (foregut, midgut or hindgut)
- Functional (carcinoid syndrome)
- Non-functional
Bronchial and Thymic Carcinoids
Hereditary Syndromes including:
- Multiple Endocrine Neoplasia (MEN)
- Neurofibromatosis type 1 (NF1)
- von Hippel–Lindau (VHL)
- SDHB and SDHD mutations
Register for the Focus On Neuroendocrine Tumors Conference
The Focus on NET Conference is free, and open to the public.Date: Friday, November 2, 2012
Time: 7:30 am to 3:15 pm
Location: Hilton Hotel, 4200 City Line Avenue, Philadelphia, PA
Registration: Register here for the conference
